MGH Summary of screen methodology_primary screen-stage 2.docx

syn3049862

Created By Roberta Beauchamp Beauchamp

assay: cellViabilityAssay
species: Human
cellType: meningioma,primary meningioma,CRISPR arachnoid
dataType: drugScreen
diagnosis: Neurofibromatosis 2
tumorType: Meningioma
consortium: Synodos
fileFormat: doc
isCellLine: TRUE
dataSubtype: metadata
nf1Genotype: unknown
nf2Genotype: +/+,-/-
individualID: Syn1,Syn2,Syn3,Syn4,Syn5,Syn6,Syn7,Syn10,Syn12
resourceType: experimentalData
fundingAgency: CTF
timePointUnit: hours
drugScreenType: singleMolecule
cellLineMetadataSynId: syn3275123
experimentalCondition: Axitinib,Bortezomib,Panobinostat,Vorinostat,GDC-0941,Ganetespib,GSK2126458,GDC-0980,CUDC907,AR-42,AZD2014,Everolimus,DMSO,media
specimenMetadataSynId: syn5569975

MGH Summary of screen methodology_primary screen-stage 2.docx page is loading…